TNF and rheumatoid arthritis: TNFα inhibitor dosage was usual: 50 mg per week for etanercept, 40 mg twice a month for adalimumab, and 3 to 5 mg/kg for 8 weeks (RA patients) or 6 weeks (AS patients) for infliximab.